Noonan Syndrome-Associated SHP2 Dephosphorylates GluN2B to Regulate NMDA Receptor Function-Reference-Cited by-同舟云学术

Noonan Syndrome-Associated SHP2 Dephosphorylates GluN2B to Regulate NMDA Receptor Function

Published:2018-08 Issue:6 Volume:24 Page:1523-1535
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Levy Aaron D.,Xiao Xiao,Shaw Juliana E.,Sudarsana Devi Suma Priya,Katrancha Sara Marie,Bennett Anton M.,Greer Charles A.,Howe James R.,Machida Kazuya,Koleske Anthony J.

Funder

NIH

American Heart Association Postdoctoral Fellowship

National Science Foundation Graduate Research Fellowship

Yale School of Medicine

Leukemia and Lymphoma Society Quest for Cures

Yale NIDA Proteomics Center

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference56 articles.

1. Aberrant neuronal activity-induced signaling and gene expression in a mouse model of RASopathy;Altmüller;PLoS Genet.,2017

2. The novel object recognition memory: neurobiology, test procedure, and its modifications;Antunes;Cogn. Process.,2012

3. Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation;Araki;Nat. Med.,2004

4. Regulation of NMDA receptors by phosphorylation;Chen;Neuropharmacology,2007

5. Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases;Chen;Nature,2016

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SHP2 regulates GluA2 tyrosine phosphorylation required for AMPA receptor endocytosis and mGluR-LTD;Proceedings of the National Academy of Sciences;2024-04-24

2. Heterozygosity for neurodevelopmental disorder-associatedTRIOvariants yields distinct deficits in behavior, neuronal development, and synaptic transmission in mice;2024-01-06

3. Design and Synthesis of 1, 2, 4-Triazole Derivatives and Evaluation of SHP-2 Activity;Hans Journal of Medicinal Chemistry;2024

4. Discovery of a potent and selective allosteric inhibitor targeting the SHP2 tunnel site for RTK-driven cancer treatment;European Journal of Medicinal Chemistry;2023-05

5. Neuronal Cannabinoid CB1 Receptors Suppress the Growth of Melanoma Brain Metastases by Inhibiting Glutamatergic Signalling;Cancers;2023-04-24